Literature DB >> 28859882

Congruence Between Latent Class and K-Modes Analyses in the Identification of Oncology Patients With Distinct Symptom Experiences.

Nikoloas Papachristou1, Payam Barnaghi1, Bruce A Cooper2, Xiao Hu2, Roma Maguire3, Kathi Apostolidis4, Jo Armes5, Yvette P Conley6, Marilyn Hammer7, Stylianos Katsaragakis8, Kord M Kober2, Jon D Levine9, Lisa McCann3, Elisabeth Patiraki10, Steven M Paul2, Emma Ream1, Fay Wright11, Christine Miaskowski12.   

Abstract

CONTEXT: Risk profiling of oncology patients based on their symptom experience assists clinicians to provide more personalized symptom management interventions. Recent findings suggest that oncology patients with distinct symptom profiles can be identified using a variety of analytic methods.
OBJECTIVES: The objective of this study was to evaluate the concordance between the number and types of subgroups of patients with distinct symptom profiles using latent class analysis and K-modes analysis.
METHODS: Using data on the occurrence of 25 symptoms from the Memorial Symptom Assessment Scale, that 1329 patients completed prior to their next dose of chemotherapy (CTX), Cohen's kappa coefficient was used to evaluate for concordance between the two analytic methods. For both latent class analysis and K-modes, differences among the subgroups in demographic, clinical, and symptom characteristics, as well as quality of life outcomes were determined using parametric and nonparametric statistics.
RESULTS: Using both analytic methods, four subgroups of patients with distinct symptom profiles were identified (i.e., all low, moderate physical and lower psychological, moderate physical and higher Psychological, and all high). The percent agreement between the two methods was 75.32%, which suggests a moderate level of agreement. In both analyses, patients in the all high group were significantly younger and had a higher comorbidity profile, worse Memorial Symptom Assessment Scale subscale scores, and poorer QOL outcomes.
CONCLUSION: Both analytic methods can be used to identify subgroups of oncology patients with distinct symptom profiles. Additional research is needed to determine which analytic methods and which dimension of the symptom experience provide the most sensitive and specific risk profiles.
Copyright © 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Symptom clusters; cancer; chemotherapy; clustering; k-modes analysis; latent class analysis; machine learning

Mesh:

Substances:

Year:  2017        PMID: 28859882      PMCID: PMC5794511          DOI: 10.1016/j.jpainsymman.2017.08.020

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  45 in total

1.  The challenge of response shift for quality-of-life-based clinical oncology research.

Authors:  M A Sprangers; C E Schwartz
Journal:  Ann Oncol       Date:  1999-07       Impact factor: 32.976

2.  Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life.

Authors:  Marylin J Dodd; Maria H Cho; Bruce A Cooper; Judy Petersen; Kayee Alice Bank; Kathryn A Lee; Christine Miaskowski
Journal:  Oncol Nurs Forum       Date:  2011-01       Impact factor: 2.172

Review 3.  Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations.

Authors:  Christine Miaskowski; Andrea Barsevick; Ann Berger; Rocco Casagrande; Patricia A Grady; Paul Jacobsen; Jean Kutner; Donald Patrick; Lani Zimmerman; Canhua Xiao; Martha Matocha; Sue Marden
Journal:  J Natl Cancer Inst       Date:  2017-01-24       Impact factor: 13.506

Review 4.  Future Directions in Symptom Cluster Research.

Authors:  Christine Miaskowski
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

5.  Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence.

Authors:  Guro Lindviksmoen Astrup; Kristin Hofsø; Kristin Bjordal; Marianne Grønlie Guren; Ingvild Vistad; Bruce Cooper; Christine Miaskowski; Tone Rustøen
Journal:  Acta Oncol       Date:  2017-01-12       Impact factor: 4.089

6.  Cancer patients' function, symptoms and supportive care needs: a latent class analysis across cultures.

Authors:  Jennifer Barsky Reese; Amanda Blackford; Jonathan Sussman; Toru Okuyama; Tatsuo Akechi; Daryl Bainbridge; Doris Howell; Claire F Snyder
Journal:  Qual Life Res       Date:  2014-01-31       Impact factor: 4.147

7.  Latent Class Analysis Reveals Distinct Subgroups of Patients Based on Symptom Occurrence and Demographic and Clinical Characteristics.

Authors:  Christine Miaskowski; Laura Dunn; Christine Ritchie; Steven M Paul; Bruce Cooper; Bradley E Aouizerat; Kimberly Alexander; Helen Skerman; Patsy Yates
Journal:  J Pain Symptom Manage       Date:  2015-01-31       Impact factor: 3.612

8.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  Impact of cancer-related symptom synergisms on health-related quality of life and performance status.

Authors:  Karine A S L Ferreira; Miako Kimura; Manoel J Teixeira; Tito R Mendoza; Jose Cláudio M da Nóbrega; Silvia R Graziani; Teresa Yae Takagaki
Journal:  J Pain Symptom Manage       Date:  2008-03-24       Impact factor: 3.612

10.  Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study.

Authors:  Kirsten K Ness; Kevin R Krull; Kendra E Jones; Daniel A Mulrooney; Gregory T Armstrong; Daniel M Green; Wassim Chemaitilly; Webb A Smith; Carmen L Wilson; Charles A Sklar; Kyla Shelton; Deo Kumar Srivastava; Sabeen Ali; Leslie L Robison; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

View more
  11 in total

1.  Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.

Authors:  Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

2.  Network Analysis of the Multidimensional Symptom Experience of Oncology.

Authors:  Nikolaos Papachristou; Payam Barnaghi; Bruce Cooper; Kord M Kober; Roma Maguire; Steven M Paul; Marilyn Hammer; Fay Wright; Jo Armes; Eileen P Furlong; Lisa McCann; Yvette P Conley; Elisabeth Patiraki; Stylianos Katsaragakis; Jon D Levine; Christine Miaskowski
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

3.  Latent Class Analysis of Symptom Burden Among Seriously Ill Adults at the End of Life.

Authors:  Komal P Murali; Gary Yu; John D Merriman; Allison Vorderstrasse; Amy S Kelley; Abraham A Brody
Journal:  Nurs Res       Date:  2021 Nov-Dec 01       Impact factor: 2.381

4.  The prevalence and risk of symptom and function clusters in colorectal cancer survivors.

Authors:  Arnold L Potosky; Kristi D Graves; Li Lin; Wei Pan; Jane M Fall-Dickson; Jaeil Ahn; Kristin M Ferguson; Theresa H M Keegan; Lisa E Paddock; Xiao-Cheng Wu; Rosemary Cress; Bryce B Reeve
Journal:  J Cancer Surviv       Date:  2021-11-17       Impact factor: 4.062

5.  Symptom Classes in Decompensated Liver Disease.

Authors:  Lissi Hansen; Michael F Chang; Shirin Hiatt; Nathan F Dieckmann; Arnab Mitra; Karen S Lyons; Christopher S Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2021-11-20       Impact factor: 13.576

6.  Changes in the Occurrence, Severity, and Distress of Symptoms in Patients With Gastrointestinal Cancers Receiving Chemotherapy.

Authors:  Ilufredo Y Tantoy; Bruce A Cooper; Anand Dhruva; Janine Cataldo; Steven M Paul; Yvette P Conley; Marilyn Hammer; Fay Wright; Laura B Dunn; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-10-17       Impact factor: 3.612

7.  Novel Claims-Based Outcome Phenotypes in Survivors of Pediatric Traumatic Brain Injury.

Authors:  Aline B Maddux; Carter Sevick; Matthew Cox-Martin; Tellen D Bennett
Journal:  J Head Trauma Rehabil       Date:  2021 Jul-Aug 01       Impact factor: 2.710

8.  Distinct profiles of multiple co-occurring symptoms in patients with gastrointestinal cancers receiving chemotherapy.

Authors:  Yufen Lin; Donald E Bailey; Sharron L Docherty; Laura S Porter; Bruce A Cooper; Steven M Paul; Kord M Kober; Marilyn J Hammer; Fay Wright; Laura B Dunn; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2021-01-16       Impact factor: 3.359

9.  Identification of Patient-Reported Outcome Phenotypes Among Oncology Patients With Palliative Care Needs.

Authors:  Tara L Kaufmann; Kelly D Getz; Jesse Y Hsu; Antonia V Bennett; Samuel U Takvorian; Arif H Kamal; Angela DeMichele
Journal:  JCO Oncol Pract       Date:  2021-03-24

10.  Distinct Sleep Disturbance Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy.

Authors:  Yufen Lin; Donald E Bailey; Sharron L Docherty; Laura S Porter; Bruce A Cooper; Steven M Paul; Marilyn J Hammer; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.